Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide - Venkat Kanamarlapudi (Cancers, 2023)
Correction to article available at https://doi.org/10.3390/cancers16051006